RATIOS
Venus Remedies Ltd.
BSE
Apr 30
304.85
-6.30 ( -2.02%)
Volume
1078
Prev. Close
311.15
Open Price
315.35
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
NSE
Apr 30
302.85
-8.70 ( -2.79%)
Volume
22329
Prev. Close
311.55
Open Price
315.00
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
You can view the
Ratio Analysis
for the last 5 years.
|
ISIN No
|
INE411B01019
|
Market Cap. ( ₹ in Cr. )
|
404.82
|
P/BV
|
0.82
|
Book Value ( ₹ )
|
369.73
|
|
BSE Code
|
526953
|
52 Week High/Low ( ₹ )
|
428/270
|
FV/ML
|
10/1
|
P/E(X)
|
14.21
|
|
NSE Code
|
VENUSREMEQ
|
Book Closure
|
23/09/2024
|
EPS ( ₹ )
|
21.31
|
Div Yield (%)
|
0.00
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | 22.82 | 21.67 | 37.12 | 43.97 | -6.67 |
| Diluted EPS (Rs.) | 22.82 | 21.67 | 37.12 | 43.97 | -6.67 |
| Cash EPS (Rs.) | 41.94 | 45.14 | 61.02 | 71.75 | 18.49 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 380.48 | 357.63 | 336.21 | 324.24 | 269.20 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 380.48 | 357.63 | 336.21 | 324.24 | 269.20 |
| Revenue From Operations / Share (Rs.) | 430.32 | 402.23 | 430.30 | 416.97 | 259.46 |
| PBDIT / Share (Rs.) | 54.02 | 53.64 | 57.79 | 52.36 | 37.79 |
| PBIT / Share (Rs.) | 34.90 | 30.17 | 33.42 | 24.59 | 12.64 |
| PBT / Share (Rs.) | 34.90 | 30.17 | 33.42 | 33.27 | -5.07 |
| Net Profit / Share (Rs.) | 22.82 | 21.67 | 36.65 | 43.97 | -6.67 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | 12.55 | 13.33 | 13.43 | 12.55 | 14.56 |
| PBIT Margin (%) | 8.11 | 7.50 | 7.76 | 5.89 | 4.86 |
| PBT Margin (%) | 8.11 | 7.50 | 7.76 | 7.97 | -1.95 |
| Net Profit Margin (%) | 5.30 | 5.38 | 8.51 | 10.54 | -2.56 |
| Return on Networth / Equity (%) | 5.99 | 6.05 | 10.90 | 13.56 | -2.47 |
| Return on Capital Employeed (%) | 8.20 | 7.52 | 9.00 | 6.61 | 3.64 |
| Return On Assets (%) | 4.75 | 4.75 | 8.46 | 9.92 | -1.28 |
| Long Term Debt / Equity (X) | 0.07 | 0.08 | 0.08 | 0.11 | 0.21 |
| Total Debt / Equity (X) | 0.07 | 0.08 | 0.08 | 0.11 | 0.46 |
| Asset Turnover Ratio (%) | 0.92 | 0.90 | 1.02 | 0.86 | 0.46 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 4.96 | 4.38 | 3.20 | 2.41 | 1.32 |
| Quick Ratio (X) | 3.34 | 2.82 | 1.68 | 1.04 | 0.67 |
| Inventory Turnover Ratio (X) | 2.97 | 2.65 | 3.04 | 2.69 | 1.23 |
| | | | | | |
| COVERAGE RATIOS | | | | | |
| | | | | | |
| Interest Coverage Ratio (%) | 0.00 | 0.00 | 0.00 | 5.08 | 3.58 |
| Interest Coverage Ratio (Post Tax) (%) | 0.00 | 0.00 | 0.00 | 3.42 | 1.04 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 407.33 | 202.58 | 348.08 | 358.63 | 180.01 |
| EV / Net Operating Revenue (X) | 0.70 | 0.37 | 0.60 | 0.69 | 0.56 |
| EV / EBITDA (X) | 5.64 | 2.83 | 4.51 | 5.55 | 3.86 |
| MarketCap / Net Operating Revenue (X) | 0.75 | 0.40 | 0.62 | 0.65 | 0.08 |
| Price / BV (X) | 0.85 | 0.45 | 0.79 | 0.84 | 0.08 |
| Price / Net Operating Revenue (X) | 0.75 | 0.40 | 0.62 | 0.65 | 0.08 |
| EarningsYield | 0.06 | 0.13 | 0.13 | 0.16 | -0.29 |